Blog
Research

Research

Access the latest research digests, from novel therapies to real-world evidence, and learn about evidence-generating medicine. Visit osmind.org/research for more.

Debunking Myths About Measurement-Based Care in Psychiatric Practice: A Psychiatrist's Perspective

Modern Solutions, Better Outcomes: A Psychiatrist's Guide to IV Ketamine

How to Get Started with Measurement-Based Care

New Real-World Evidence Supports Esketamine Nasal Spray as an Effective Treatment for Treatment-Resistant Depression

Comparative Effects of Esketamine and IV Ketamine for Major Depression: A Real-World Analysis

Evaluating TMS vs ECT vs Ketamine vs Esketamine

Embracing Pragmatism for Ketamine Insurance Coverage: Leveraging Real-World Evidence

Harnessing the Power of Microdosing and Wearables: Unveiling the Psynautics Clinical Neuroscience Study

Clinical Trials and Breakthrough Treatments with Michael Banov, MD

Can We Predict Ketamine Therapy Outcomes for Depression? This Model May Hold Promise

7 Predictions on Psychiatry's Future: Experts Weigh In

Surprising Insights from Psychedelic Science 2023: Gul Dolen, Elias Dakwar, Michael Bogenschutz, and Karen Luong: Duration of experience, Psilocybin for Substance Abuse, and Legal Challenges

Osmind Announces Publication of Largest Real-World Study on Effectiveness of Ketamine Intravenous Therapy for Depression, Anxiety and Suicidal Ideation

Bridging the Gap Between Research and Practice: Insights from Osmind's Research Interest Survey

Psychopharmacology of Psychedelics: What Every Psychiatrist Needs to Tell Their Patients on SSRIs with Dr. Kelan Thomas

Measurement-Based Care: How to Improve Clinical Outcomes in Mental Health

ACNP 2022 highlight: The Role of KORs in Mediating Stress-Related Deficits in Reward Processing: MOA of Ketamine and Aticaprant

Osmind 2022 Year in Review: A Breakthrough Year for Mental Health Care

The State of Innovative Mental Health Care pt.3: Future Predictions

The State of Innovative Mental Health Care pt. 1: Access to Care and Insurance Challenges

The Pivotal Role of Music in Ketamine and Psychedelic Treatments

Real-world evidence and ketamine infusion therapy: 2022 has been a good year

How to use measurement-based care to achieve better outcomes for patients with treatment-resistant depression

Will ‘passive sensing’ impact the treatment of depression?

Andrew Penn AMA Recap

logo

Insights

AboutCareersBlogPodcastAffiliate

If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255.

Osmind Inc. © 2024 All Rights Reserved.

Privacy Policy

Terms of Service